The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24
July 17 2019 - 07:00AM
Business Wire
The Medicines Company (NASDAQ: MDCO) will host a conference call
and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to
discuss its second quarter 2019 financial results and operational
developments.
The conference call may be accessed by telephone as follows:
U.S./Canada:
(877) 407-0312
International:
(201) 389-0899
Conference ID:
13692457
A live audio webcast of the conference call may be accessed in
the Investors section of The Medicines Company website.
A taped replay of the conference call will be available after
the call concludes, and may be accessed by telephone as
follows:
U.S./Canada:
(877) 660-6853
International:
(201) 612-7415
Conference ID:
13692457
An archived webcast will be also be available after the call
concludes.
About The Medicines Company
The Medicines Company is a biopharmaceutical company whose
purpose is to halt the deadly progression of atherosclerosis and
the cardiovascular risk created by high levels of LDL-C, or bad
cholesterol. Our team is focused on transformational solutions that
address the daily challenges that patients, physicians and payers
confront in cardiovascular care. The Company is headquartered in
Parsippany, New Jersey. For more information, please visit
www.themedicinescompany.com and follow us on Twitter @MDCONews and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190717005011/en/
Investor Relations Krishna Gorti, M.D. Vice President,
Investor Relations 973 290 6122 krishna.gorti@themedco.com Media
Inquiries Michael Blash Vice President, Communications 973 290
6100 michael.blash@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2023 to Mar 2024